29 results
8-K
EX-99.2
CCCC
C4 Therapeutics Inc
11 Aug 21
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
4:07pm
or clinical trials in any future studies or trials; the impact of COVID-19 on our operations, clinical trials and supply chain; our current resources
8-K
EX-99.1
CCCC
C4 Therapeutics Inc
13 May 21
C4 Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
4:22pm
; anticipated revenue under our existing collaboration agreements; the impact of COVID-19 on our operations, clinical trials and supply chain; our current
8-K
EX-99.1
CCCC
C4 Therapeutics Inc
11 Aug 21
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
4:07pm
agreements; the impact of COVID-19 on our operations, clinical trials and supply chain; our current resources and cash runway; and regulatory developments
S-3ASR
CCCC
C4 Therapeutics Inc
10 Nov 21
Automatic shelf registration
5:19pm
, manufacturing, clinical trials, research programs, supply chain, regulatory review, healthcare systems or the global economy as a whole;
risks related … , potential clinical trials, regulatory review or supply chain disruptions, and other potential impacts to our business, the effectiveness or timeliness
ARS
or9yk
28 Apr 23
Annual report to shareholders
7:03am
10-Q
xblos8a
12 Nov 20
Quarterly report
4:28pm
DRS
6e9 834phynlesb
19 May 21
Draft registration statement
12:00am
424B4
4i2o1u6ls1knvzbah6
21 Jun 21
Prospectus supplement with pricing info
8:08am